Literature DB >> 1180547

Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.

A S Hackman, T D Wilkins.   

Abstract

Cefoxitin, a beta-lactamase-resistant cephalosporin, was found to be more effective than cephalothin against an experimental mixed infection containing Bacteroides fragilis and Fusobacterium necrophorum.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1180547      PMCID： PMC429293          DOI： 10.1128/AAC.8.2.224

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  3 in total

1.  Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.

Authors:  T D Wilkins; L D Smith
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

2.  Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.

Authors:  H Wallick; D Hendlin
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

3.  In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.

Authors:  A S Hackman; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191
  3 in total
  8 in total

1.  Susceptibility of anaerobic bacteria to cofoxitin and related compounds.

Authors:  V T Bach; I Roy; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

Review 2.  Fusobacterium necrophorum: its characteristics and role as an animal pathogen.

Authors:  B F Langworth
Journal:  Bacteriol Rev       Date:  1977-06

3.  Chemotherapy of an experimental Bacteroides fragilis infection in mice.

Authors:  C B Walker; D Nitzan; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).

Authors:  C Krasemann; H Werner; G Hildenbrand; M Benning; U Brandt; J Ungerechts
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.

Authors:  P L Goldman; D T Durack; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

Review 6.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

7.  Comparison of extracellular enzymes of Fusobacterium necrophorum subsp. necrophorum and Fusobacterium necrophorum subsp. funduliforme.

Authors:  K K Amoako; Y Goto; T Shinjo
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  [In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].

Authors:  H Werner; R Firsching; C Krasemann
Journal:  Infection       Date:  1977       Impact factor: 3.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.